News
IRIX
3.180
-2.75%
-0.090
Weekly Report: what happened at IRIX last week (0408-0412)?
Weekly Report · 2d ago
Weekly Report: what happened at IRIX last week (0401-0405)?
Weekly Report · 04/08 11:21
Weekly Report: what happened at IRIX last week (0325-0329)?
Weekly Report · 04/01 11:18
Iridex's Strategic Review Process Should Bear Fruit 'Soon'
Iridex Corporation is undergoing a strategic review process to unlock shareholder value. The company is likely to sell its retina business line and potentially parse it out "soon" The glaucoma business line is highly promising but needs to be in the hands of a bigger company to reach its full potential. Iridex is a leader in ophthalmic technology for the treatment of retinal and glau coma diseases. The entire business may be worth double the current share prices.
Seeking Alpha · 03/28 23:12
12 Health Care Stocks Moving In Thursday's After-Market Session
Qilian Intl Hldg Gr (NASDAQ:QLI) shares increased by 73.2% to $1.1 during Thursday's after-market session. Dare Bioscience stock rose 12.19% and Sunshine Biopharma stock increased by 37.85%. Vivos Therapeutics stock fell 12.6% as the company's Q4 earnings came out today.
Benzinga · 03/28 20:31
Analysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX), Iridex (IRIX) and Keros Therapeutics (KROS)
TipRanks · 03/27 12:40
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023
Iridex reported earnings per share of -18 cents for the fourth quarter of 2023. The company reported revenue of $12.46 million. This was 16.39% worse than the analyst estimate for revenue. Iridex also reported results for the third quarter of 2018.
Investorplace · 03/27 00:53
Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates
NASDAQ · 03/26 22:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
Apollomics (NASDAQ:APLM) stock rose 10.9% to $0.61 during Tuesday's after-market session. The company's, Q4 earnings came out today. Cara Therapeutics shares moved upwards by 7.36% and Iridex stock increased by 5.52%. Losers Akili and Mira Pharmaceuticals were the biggest losers in the market.
Benzinga · 03/26 21:32
IRIDEX Corp reports results for the quarter ended in December - Earnings Summary
IRIDEX Corp reports a quarterly adjusted loss of 18 cents per share for the quarter ended in December. Revenue fell 18% to $12.46 million from a year ago. The company reported a quarterly loss of $2.96 million. IRIDEX shares had fallen by 7.8% this quarter.
Reuters · 03/26 21:01
Iridex: Q4 Earnings Insights
Iridex reported its Q4 earnings on March 26, but missed estimates by $0.18. The company's revenue was down $2.74 million from the same period last year. Iridex is expected to announce its earnings on Tuesday, March 26.
Benzinga · 03/26 20:30
IRIDEX GAAP EPS of -$0.18 misses by $0.13, revenue of $12.5M misses by $2.4M
IRIDEX Corporation (IRIX) reports Q4 GAAP EPS of -$0.18 misses by $0.13, revenue of $12.5M misses by $2.4M. The company is expected to report its quarterly results on March 26.
Seeking Alpha · 03/26 20:18
*Iridex 4Q R&D Expense $1.7M >IRIX
Dow Jones · 03/26 20:09
*Iridex 4Q Retina Pdt Rev $7.5M, Down 7% >IRIX
Dow Jones · 03/26 20:08
*Iridex 4Q Cyclo G6 Pdt Family Rev $3M >IRIX
Dow Jones · 03/26 20:08
*Iridex 4Q Loss $2.96M >IRIX
Dow Jones · 03/26 20:05
*Iridex 4Q Loss/Shr 18c >IRIX
Dow Jones · 03/26 20:05
*Iridex 4Q Rev $12.5M >IRIX
Dow Jones · 03/26 20:05
After-Hours Earnings Report for March 26, 2024 : GME, CNXC, NCNO, PRGS, FRGE, BCAB, DRCT, LUXH, IRIX, BIOR, RVYL, APTO
NASDAQ · 03/26 18:00
More
Webull provides a variety of real-time IRIX stock news. You can receive the latest news about Iridex through multiple platforms. This information may help you make smarter investment decisions.
About IRIX
IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.